Cross-links at abasic sites in duplex DNA
Cross-links at abasic sites in duplex DNA
批准号:
10295786
负责人:
Kent S Gates
金额:
$39.63万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-15 至 2023-10-31
关键词:
AdenineAgingAldehydesAlkylationAreaBRCA1 geneBiologicalBiologyBypassCancer EtiologyCell DeathCellsChemicalsChemistryCoupledDNADNA DamageDNA RepairDNA Sequence AlterationDNA biosynthesisDeaminationDilution TechniquesDiseaseEnvironmental CarcinogensEnzymesEvolutionExposure toFailureFunctional disorderGenerationsGeneticGenetic CodeGenetic VariationGenomeGlycosidesGrantGuanineHealthHumanHydrolysisIn VitroIndividualInheritedLaboratoriesLeadLesionLifeLightMalignant NeoplasmsMethodsMutagenesisMutationNEIL3 geneNerve DegenerationNucleic AcidsOligonucleotidesPharmacologyPolymerasePredispositionProcessRandomizedReactionResearchRoleShuttle VectorsSiteSourceSystemTissuesWalkingWorkamino groupcarcinogenesiscigarette smokecrosslinkdetection methodendonucleasegenetic informationhealthspanimprovedinnovationinsightnext generation sequencingnovelnucleobaseoxidationreconstitutionrepairedstable isotope
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Endogenous DNA damage can contribute to aging, sporadic cancers, and neurodegeneration. There are
many sources of endogenous DNA damage, including oxidation, alkylation, nucleobase deamination, and
hydrolysis of the glycosidic bond to generate abasic sites. DNA repair systems mitigate the effects of these
endogenous damages, but some lesions inevitably evade repair with deleterious consequences. Importantly,
not all DNA damage is created equal. Interstrand cross-links are exceptionally bioactive lesions because they
block the DNA strand separation required for read-out and replication of genetic information in cells. Cells
have no good answer to cross-links in their genome: Failure to repair cross-links may lead to cell death,
tissue dysfunction, and aging, while error-prone repair may result in mutagenesis and cancer. The evolution
and retention of elaborate cross-link repair systems across all walks of life suggest that the generation of
endogenous interstrand cross-links is an unavoidable fact of life, but the identities of these cross-links and
their biological consequences remain uncertain. The long-term objective of this application is to assess the
occurrence and biological endpoints of endogenous DNA cross-links, which will contribute significantly to
overall understanding of cancer etiology. Work during the previous grant period characterized a group of
interstrand cross-links derived from an abasic (Ap) site that is the most common endogenous lesion found in
cellular DNA. The work further developed LC-MS methods for the detection and characterization of these
lesions in duplex DNA, and described a shuttle vector method for assessing the efficiency and fidelity with
which the Ap-derived cross-links are repaired and replicated in human cells. The proposed work, will (1)
conduct unbiased screens to comprehensively determine the sequence hotspots for Ap-derived cross-link
formation, (2) detect the occurrence of Ap-derived cross-links in cellular DNA, and (3) determine the
efficiency and fidelity with which Ap-derived cross-links are repaired in human cells and define the
mechanisms of replication-dependent cross-link “unhooking” in vitro and in human cells. The proposed work
explores the hypothesis that formation and replication-coupled repair of Ap-derived cross-links may be
particularly important in cancer, neurodegeneration, and aging. The work is significant because the
formation and repair of endogenous DNA cross-links may contribute to the causal processes involved in
aging and early carcinogenesis. The work is innovative because it examines structurally novel cross-links
and novel repair mechanisms, thus promising novel insights regarding the roles of endogenous DNA damage
in human health and disease. In the long run, the results may enable understanding of how genetic
differences in cross-link repair capacity contribute to human healthspan. Ultimately such insights could
inspire approaches that improve health by genetic means or by pharmacological agents that inhibit the
formation and/or enhance the repair of endogenous cross-links.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cross-links at abasic sites in duplex DNA
-
批准号:10524017
-
项目类别:
-
资助金额:$39.47万
-
财政年份:2012
-
负责人:Kent S Gates
-
依托单位:
Cross-links At Abasic Sites in Duplex DNA
-
批准号:8664848
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2012
-
负责人:Kent S Gates
-
依托单位:
Cross-links At Abasic Sites in Duplex DNA
-
批准号:8867233
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2012
-
负责人:Kent S Gates
-
依托单位:
Cross-links At Abasic Sites in Duplex DNA
-
批准号:8372731
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2012
-
负责人:Kent S Gates
-
依托单位:
Cross-links at abasic sites in duplex DNA
-
批准号:10054954
-
项目类别:
-
资助金额:$39.78万
-
财政年份:2012
-
负责人:Kent S Gates
-
依托单位:
Cross-links At Abasic Sites in Duplex DNA
-
批准号:8531243
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2012
-
负责人:Kent S Gates
-
依托单位:
Chemical and Biological Mechanisms of Leinamycin
-
批准号:7028123
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2006
-
负责人:Kent S Gates
-
依托单位:
Chemical and Biological Mechanisms of Leinamycin
-
批准号:7286021
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2006
-
负责人:Kent S Gates
-
依托单位:
Conference Grant: "DNA Alkylation: From Natural Products to Chemotherapy"
-
批准号:7159973
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2006
-
负责人:Kent S Gates
-
依托单位:
Chemical and Biological Mechanisms of Leinamycin
-
批准号:7470547
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2006
-
负责人:Kent S Gates
-
依托单位:
Chemical and Biological Mechanisms of Leinamycin
-
批准号:7663837
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2006
-
负责人:Kent S Gates
-
依托单位:
Chemical and Biological Mechanisms of Leinamycin
-
批准号:7900900
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2006
-
负责人:Kent S Gates
-
依托单位:
DNA Damage by Tumor Cell-Specific N-Oxides
-
批准号:6858673
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2003
-
负责人:Kent S Gates
-
依托单位:
DNA Damage by Tumor Cell-Specific N-Oxides
-
批准号:6602990
-
项目类别:
-
资助金额:$17.04万
-
财政年份:2003
-
负责人:Kent S Gates
-
依托单位:
DNA Damage by Tumor Cell-Specific N-Oxides
-
批准号:6717697
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2003
-
负责人:Kent S Gates
-
依托单位:
DNA Damage by Tumor Cell-Specific N-Oxides
-
批准号:7016287
-
项目类别:
-
资助金额:$16.62万
-
财政年份:2003
-
负责人:Kent S Gates
-
依托单位:
DNA ALKYLATION BY THE ANTITUMOR ANTIBIOTIC LEINAMYCIN
-
批准号:6031193
-
项目类别:
-
资助金额:$15.7万
-
财政年份:1999
-
负责人:Kent S Gates
-
依托单位:
DNA Alkylation by Leinamycin
-
批准号:6989438
-
项目类别:
-
资助金额:$18.96万
-
财政年份:1999
-
负责人:Kent S Gates
-
依托单位:
DNA Alkylation by Leinamycin
-
批准号:7424973
-
项目类别:
-
资助金额:$17.98万
-
财政年份:1999
-
负责人:Kent S Gates
-
依托单位:
DNA Alkylation by Leinamycin
-
批准号:7072155
-
项目类别:
-
资助金额:$18.52万
-
财政年份:1999
-
负责人:Kent S Gates
-
依托单位:
海外基金